Author: TransCelerate BioPharma/ Zero To Five, LLC

Posted Date:

May 5, 2026

TransCelerate and FDA Advance Collaboration on Streamlined Safety Data Collection to Accelerate Inclusion of Pragmatic Elements in Clinical Trials

TransCelerate BioPharma/ Zero To Five, LLC

May 5, 2026
TransCelerate to Advance Industry Dialogue on Patient-Centered Innovation, AI and Real-World Evidence at PHUSE US Connect 2026

TransCelerate BioPharma/ Zero To Five, LLC

March 12, 2026
TransCelerate BioPharma Releases 2025 Annual Report Highlighting The Power of Forward in Clinical R&D

TransCelerate BioPharma/ Zero To Five, LLC

February 19, 2026
TransCelerate BioPharma Showcases Approaches to Advancing Clinical Trial Efficiency and Patient-Centered Design at SCOPE US 2026

TransCelerate BioPharma/ Zero To Five, LLC

January 28, 2026